Influence of private practice setting and physician characteristics on the use of breast cancer adjuvant chemotherapy for elderly women (Q37408456)

20 August 2017

Influence of private practice setting and physician characteristics on the use of breast cancer adjuvant chemotherapy for elderly women (English)

1 reference

20 August 2017

1 reference

1 reference

1

Dawn L Hershman

1 reference

20 August 2017

5

Alfred I Neugut

1 reference

20 August 2017

Donna Buono

2

1 reference

20 August 2017

Russell B McBride

series ordinal

3

1 reference

20 August 2017

Wei Yann Tsai

series ordinal

4

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 September 2009

1 reference

20 August 2017

1 reference

20 August 2017

115

1 reference

20 August 2017

17

1 reference

20 August 2017

3848-3857

1 reference

The role of the surgeon in whether patients with lymph node-positive colon cancer see a medical oncologist

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

Medical oncologists' views on communicating with patients about chemotherapy costs: a pilot survey

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

Determinants of androgen deprivation therapy use for prostate cancer: role of the urologist

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

Effectiveness of adjuvant chemotherapy for node-positive operable breast cancer in older women

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

Breast cancer treatment in clinical practice compared to best evidence and practice guidelines

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

Discrepancy between consensus recommendations and actual community use of adjuvant chemotherapy in women with breast cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

Population-based assessment of hospitalizations for toxicity from chemotherapy in older women with breast cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

Linking physician characteristics and medicare claims data: issues in data availability, quality, and measurement

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

Utility of the SEER-Medicare data to identify chemotherapy use.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

Development of a comorbidity index using physician claims data

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

Why do physicians vary so widely in their referral rates?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

Models for longitudinal data: a generalized estimating equation approach

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

Surgeon characteristics and receipt of adjuvant radiotherapy in women with breast cancer.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

NCCN Breast Cancer Practice Guidelines. The National Comprehensive Cancer Network

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

Physician reimbursement by salary or fee-for-service: effect on physician practice behavior in a randomized prospective study.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

Racial disparities and socioeconomic status in association with survival in a large population-based cohort of elderly patients with colon cancer

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

Properties of analysis methods that account for clustering in volume-outcome studies when the primary predictor is cluster size

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

Do oncologists believe new cancer drugs offer good value?

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

Older women with breast carcinoma are less likely to receive adjuvant chemotherapy: evidence of possible age bias?

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

Drug sales bring huge profits, and scrutiny, to cancer doctors: insurers and experts see high costs and conflicts.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

Impact of referral patterns on the use of chemotherapy for lung cancer.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2771700

The effects of payment method on clinical decision-making: physician responses to clinical scenarios

2 September 2018

1 reference

12 December 2020

Consensus conference. Adjuvant chemotherapy for breast cancer

1 reference

12 December 2020

Assessing illness severity: does clinical judgment work?

1 reference

12 December 2020

NIH consensus conference. Treatment of early-stage breast cancer

1 reference

12 December 2020

Physician response to patient insurance status in ambulatory care clinical decision-making. Implications for quality of care

1 reference

12 December 2020

Physicians' reasons for failing to deliver effective breast cancer care: a framework for underuse

1 reference

12 December 2020

Use and Outcomes of Adjuvant Chemotherapy in Older Women With Breast Cancer

1 reference

12 December 2020

Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort

1 reference

12 December 2020

Identifiers

DOI

10.1002/CNCR.24448

1 reference

20 August 2017

1 reference

20 August 2017

1 reference